The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation

Jobanputra, P., Barton, P., Bryan, S., Burls, A.·2002·Health Technology Assessment
DOI 10.3310/hta6210

Cited by (126)

Items 101–126 of 126

  1. Systematic review and analysis of evidences on clinical efficacy and cost-effectiveness of biological drugs for the treatment of rheumatoid arthritis
    Márta Péntek, Petra Baji, Valentin Brodszky, László Gulàcsi, Orsolya Balogh, Noémi Vártokné Hevér · 2014 · Corvinus Research Archive (Corvinus University of Budapest)
  2. Cost-effective approaches to influenza prevention and treatment
    Michael B. Rothberg · 2005 · Expert Review of Pharmacoeconomics & Outcomes Research
  3. Cost-Effectiveness of New Biologics for Rheumatoid Arthritis and Osteoarthritis
    Yolanda Bravo Vergel, David John Torgerson · 2008 · Springer eBooks
  4. TNF-blocking therapy in rheumatoid arthritis and ankylosing spondylitis: Why is cost-effectiveness a major issue?
    Sonja Merkesdal, Henning K. Zeidler · 2005 · Current Rheumatology Reports
  5. Influence des pratiques médicales sur les coûts de traitement de la polyarthrite rhumatoïde par biothérapie anti-TNFα en France
    Bruno Fautrel, Marie-Christine Woronoff-Lemsi, Morgane Ethgen, Estelle Fein, Pierre Monnet, Jean Sibilia, Daniel Wendling · 2005 · Revue du Rhumatisme
  6. Principles of health economics and application to rheumatic disorders
    Hilal Maradit Kremers, Sherine E. Gabriel, Michael Drummond · 2011 · Elsevier eBooks
  7. Applying Study Results to Patient Care: Glossary of Study Design and Statistical Terms
    Jill N. Allen · 2004
  8. Ambulatory diagnosis of endometrial pathology
    Thomas Justin Clark · 2003 · University of Birmingham Institutional Research Archive (University of Birmingham)
  9. Exploring the capability approach in model-based economic evaluations
    Paul Mark Mitchell · 2013 · University of Birmingham Institutional Research Archive (University of Birmingham)
  10. Health services research in rheumatology: a great deal accomplished, a great deal left to do
    Sheikh Usman Iqbal, Mark J. Prashker · 2004 · Rheumatic Disease Clinics of North America
  11. Artritis reumatoide: ¿cuán cara es?
    Rafael Ariza‐Ariza, Blanca Hernández‐Cruz · 2007 · Seminarios de la Fundación Española de Reumatología
  12. Valutazione economica di etanercept nel trattamento dell’Artrite Reumatoide
    Roberto Ravasio, Carlo Lucioni · 2006 · PharmacoEconomics Italian Research Articles
  13. Evaluating Treatment Strategies in Patients with Early Rheumatoid Arthritis: Merging Modeling Theory with Clinical Practice
    Annelies E. R. C. H. Boonen, Johan Louis Severens · 2011 · The Journal of Rheumatology
  14. Farmacoeconomic impact of anti-TNFα
    G Leardini, Claudio Bernardi, E. Vaccaro · 2011 · Reumatismo
  15. A pilot study and retrospective chart review comparing adalimumab, infliximab, and etanercept in patients with active rheumatoid arthritis
    Shana Arnhold · 2006 · Holmes Museum Of Anthropology (Wichita State University)
  16. The Cholinergic Anti-inflammatory Pathway: Connecting the Mind and Body
    Christopher J. Czura, Samuel Friedman, Kevin J. Tracey · 2006 · Springer eBooks
  17. Egészségügyi technológiák gazdasági elemzése krónikus betegségekben: lehetőségek és kihívások Magyarország számára
    Noémi Vártokné Hevér · 2014
  18. New guidelines to prevent atherosclerosis.
    Stephen Brunton · 1991 · PubMed Central
  19. Economic analysis of the link between advances in biopharmaceutical manufacturing and healthcare delivery costs
    Ebenezer Kwabena Tetteh · 2016 · UCL Discovery (University College London)
  20. Drogas modificadoras do curso da doença no tratamento da Artrite Reumatoide: sintéticos combinados versus agentes biológicos: revisão sistemática e estudo econômico
    Henry Dan Kiyomoto · 2018
  21. Assessing the cost-effectiveness of tumor necrosis factor inhibitors and prescribing practices of rheumatologists in patients with rheumatoid arthritis
    Khalid M. Kamal · 2005
  22. Health economics of rheumatoid arthritis
    David Lloyd Scott, Allan Wailoo · 2020
  23. Evaluación económica del tratamiento con medicamentos biológicos para artritis reumatoide refractaria a medicamentos convencionales en una cohorte colombiana
    Alcibiades Calderón Zapata · 2021
  24. TNF-α inhibitors
    Zuhre N Tutuncu, Arthur Kavanaugh · 2005 · Birkhäuser Basel eBooks
  25. Análise de custo do tratamento medicamentoso da artrite reumatóide
    Roberta Dyonísio Canaveira Monteiro · 2017
  26. Recommandations de la Société française de rhumatologie pour l'utilisation des agents anti-TNFα chez les personnes souffrant de polyarthrite rhumatoïde
    Bruno Fautrel, Arnaud Constantin, Jacques Morel, Olivier Vittecoq, Alain G Cantagrel, Bernard G Combe, Maxime Dougados, Xavier Le Loët, Xavier Mariette A, Thao Pham et al. · 2006 · Revue du Rhumatisme